echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nature Cancer: Let cancer cells "stay awake"!

    Nature Cancer: Let cancer cells "stay awake"!

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a research team from the Icahn School of Medicine at Mount Sinai in the United States came up with an idea: to permanently stay in the dormant phase of tumor cells (that is, the cell cycle is arrested in the G0/G1 phase), and have been "sleeping"! The study, recently published in Nature Cancer, elucidates the critical role of the extracellular matrix in the tumor microenvironment for tumor cells to enter and maintain a dormant state
    .

    Research results (Source: Nature Cancer)

    First, the researchers started with the three-dimensional organization of the collagen extracellular matrix (ECM), the "home ground" of dormant tumor cells
    .


    To this end, they inoculated dormant tumor cell lines and proliferating tumor cell lines into mice by tail vein injection.


    Under multiphoton second-harmonic imaging, the results showed that collagen fibers surrounding dormant cells are characterized by nonlinear arrangement and wave-like structure, and can switch to a highly linear state during cancer cell reactivation
    .

    Dormant tumor cells and proliferating tumor cells (Source: Nature Cancer)

    Since the ECM of dormant and proliferating tumors is structurally different, the investigators sought to determine whether the composition or "matrix body" of decellularized proliferating and dormant tumors by mass spectrometry different
    .


    The results showed that dormant cells formed small nodules in vivo, while proliferating tumors formed growing tumor clumps in vivo


    Comparison of collagen types between T-HEp3 (proliferating tumor) and D-HEp3 (dormant tumor) (Image source: Nature Cancer)

    Next, the researchers used a human-mouse xenograft system to further determine the relative contribution of tumor cells (human protein sequences) and stromal cells (mouse protein sequences) to matrix body production
    .


    Tests showed that collagen type III was most abundant in dormant tumor cells compared to proliferating cells


    Comparison of the density of various types of collagen (Source: Nature Cancer)

    Could a bioengineered scaffold of type II collagen treat locally residual cancer cells (as observed after primary tumor resection) prevent residual dormant cancer cells from being awakened? To this end, the study used T-HEp3 expressing the CDK2 biosensor Cells, the final results showed that only 20 percent of mice treated with scaffolded type III collagen relapsed after tumor surgery, compared with 80 percent of tumors in the control group
    .

     

     Local tumor recurrence after surgery (Source: Nature Cancer)

    As the increased abundance of type III collagen correlates with high expression of COL3A1 (part of a gene network that operates during dormancy in cancer cells) at the mRNA and protein levels
    .


    To determine the role of COL3A1 in maintaining cancer cell dormancy, the researchers used siRNA to knock down COL3A1 in quiescent D-HEp3 cells and performed in vivo growth experiments


    Finally, the researchers discovered a positive feedback pathway between collagen type III and dormant tumor cells: collagen type III binds to the tumor cell DDR1 receptor, activating STAT1 (a potential transcription factor downstream of DDR1 that regulates dormancy) into the nucleus The expression of COL3A1 is promoted, and then the tumor cells secrete type III collagen, which in turn maintains the tumor cells in a dormant state
    .

    Positive feedback pathway between type III collagen and dormant tumor cells (Credit: Nature Cancer)

    Overall, this study describes a novel mechanism of cell dormancy: the addition of type III collagen to the tumor microenvironment can promote tumor cells to enter and maintain a dormant state, inhibiting tumor proliferation
    .


    Let us look forward to the clinical use of type III collagen as a marker for tumor recurrence to prevent tumor recurrence and metastasis in the near future


    [1] Di Martino, JS, Nobre, AR, Mondal, C.


    [2] Sosa MS, Bragado P, Aguirre-Ghiso JA.


    [3] New breakthrough in tumor! Nature Cancer: This collagen can make tumor cells go dormant! https://mp.


    https://mp.
    weixin.
    qq.
    com/s/ihmuc7vJKeYNVku_ENX7owLeave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.